William Hoskins

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Activities & Behaviors

Drug Evaluation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Chi Dennis S; Ramirez Pedro T; Teitcher Jerrold B; Mironov Svetlana; Sarasohn Debra M; Iyer Revathy B; Eisenhauer Eric L; Abu-Rustum Nadeem R; Sonoda Yukio; Levine Douglas A; Brown Carol L; Aghajanian Carol; Gershenson David M; Hoskins William J; Hricak Hedvig; Barakat Richard R
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
Alektiar Kaled M; McKee Andrea; Lin Oscar; Venkatraman Ennapadam; Zelefsky Michael J; McKee Brady; Hoskins William J; Barakat Richard R
Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
Alektiar Kaled M; McKee Andrea; Lin Oscar; Venkatraman Ennapadam; Zelefsky Michael J; Mychalczak Boris R; McKee Brady; Hoskins William J; Barakat Richard R
The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of William Hoskins (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2007: Chi Dennis S; Ramirez Pedro T; Teitcher Jerrold B; Mironov Svetlana; Sarasohn Debra M; Iyer Revathy B; Eisenhauer Eric L; Abu-Rustum Nadeem R; Sonoda Yukio; Levine Douglas A; Brown Carol L; Aghajanian Carol; Gershenson David M; Hoskins William J; Hricak Hedvig; Barakat Richard R
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4946-51.
2002: Alektiar Kaled M; McKee Andrea; Lin Oscar; Venkatraman Ennapadam; Zelefsky Michael J; McKee Brady; Hoskins William J; Barakat Richard R
Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
International journal of radiation oncology, biology, physics 2002;54(1):79-85.
2002: Alektiar Kaled M; McKee Andrea; Lin Oscar; Venkatraman Ennapadam; Zelefsky Michael J; Mychalczak Boris R; McKee Brady; Hoskins William J; Barakat Richard R
The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Cancer 2002;95(2):316-21.
2002: Alektiar Kaled M; McKee Andrea; Venkatraman Ennapadam; McKee Brady; Zelefsky Micheal J; Mychalczak Boris R; Hoskins William J; Barakat Richard R
Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
International journal of radiation oncology, biology, physics 2002;53(3):707-13.
2002: Levine Douglas A; Hoskins William J
Update in the management of endometrial cancer.
Cancer journal (Sudbury, Mass.) 2002;8 Suppl 1():S31-40.
2002: Barakat Richard R; Sabbatini Paul; Bhaskaran Dharmendra; Revzin Margarita; Smith Alex; Venkatraman Ennapadam; Aghajanian Carol; Hensley Martee; Soignet Steven; Brown Carol; Soslow Robert; Markman Maurie; Hoskins William J; Spriggs David
Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):694-8.
2001: Chi D S; Liao J B; Leon L F; Venkatraman E S; Hensley M L; Bhaskaran D; Hoskins W J
Identification of prognostic factors in advanced epithelial ovarian carcinoma.
Gynecologic oncology 2001;82(3):532-7.
2001: Abu-Rustum N R; Hoskins W J
Radical abdominal hysterectomy.
The Surgical clinics of North America 2001;81(4):815-28.
2001: Sonoda Y; Zerbe M; Smith A; Lin O; Barakat R R; Hoskins W J
High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Gynecologic oncology 2001;80(3):378-82.
2001: Husain A; Chi D S; Prasad M; Abu-Rustum N; Barakat R R; Brown C L; Poynor E A; Hoskins W J; Curtin J P
The role of laparoscopy in second-look evaluations for ovarian cancer.
Gynecologic oncology 2001;80(1):44-7.
2001: Chi D S; Jones W B; Barakat R R; O'Keefe K N; Hoskins W J; Lewis J L
The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents.
European journal of gynaecological oncology 2001;22(4):266-8.
2000: Barakat R R; Gilewski T A; Almadrones L; Saigo P E; Venkatraman E; Hudis C; Hoskins W J
Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(20):3459-63.
2000: Husain A; Curtin J; Brown C; Chi D; Hoskins W; Poynor E; Alektiar K; Barakat R
Continent urinary diversion and low-rectal anastomosis in patients undergoing exenterative procedures for recurrent gynecologic malignancies.
Gynecologic oncology 2000;78(2):208-11.
2000: Boyd J; Sonoda Y; Federici M G; Bogomolniy F; Rhei E; Maresco D L; Saigo P E; Almadrones L A; Barakat R R; Brown C L; Chi D S; Curtin J P; Poynor E A; Hoskins W J
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
JAMA : the journal of the American Medical Association 2000;283(17):2260-5.
2000: Chi D S; Venkatraman E S; Masson V; Hoskins W J
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.
Gynecologic oncology 2000;77(2):227-31.
1999: Chi D S; Gemignani M L; Curtin J P; Hoskins W J
Long-term experience in the surgical management of cancer of the uterine cervix.
Seminars in surgical oncology 1999;17(3):161-7.
1999: Husain A; Sabbatini P; Spriggs D; Fennelly D; Aghajanian C; Barakat R; Curtin J; Venkatraman E; Hoskins W; Markman M
Phase II trial of intraperitoneal cisplatin and mitoxantrone in patients with persistent ovarian cancer.
Gynecologic oncology 1999;73(1):96-101.
1998: Begg C B; Cramer L D; Hoskins W J; Brennan M F
Impact of hospital volume on operative mortality for major cancer surgery.
JAMA : the journal of the American Medical Association 1998;280(20):1747-51.
1998: Aghajanian C; Fennelly D; Shapiro F; Waltzman R; Almadrones L; O'Flaherty C; O'Conner K; Venkatraman E; Barakat R; Curtin J; Brown C; Reich L; Wuest D; Norton L; Hoskins W; Spriggs D R
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1852-60.
1997: Finstad C L; Lloyd K O; Federici M G; Divgi C; Venkatraman E; Barakat R R; Finn R D; Larson S M; Hoskins W J; Humm J L
Distribution of radiolabeled monoclonal antibody MX35 F(ab')2 in tissue samples by storage phosphor screen image analysis: evaluation of antibody localization to micrometastatic disease in epithelial ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(8):1433-42.
1997: Hoskins W; Rice L; Rubin S
Ovarian cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines.
Oncology (Williston Park, N.Y.) 1997;11(6):896-900, 903-4.
1997: Fennelly D W; Aghajanian C; Shapiro F; O'Flaherty C; O'Connor K; Curtin J P; Crown J P; Hoskins W J; Spriggs D R
Dose escalation of paclitaxel with high-dose carboplatin using peripheral blood progenitor cell support in patients with advanced ovarian cancer.
Seminars in oncology 1997;24(1 Suppl 2):S2-26-S2-30.
1997: Curtin J P; Malik R; Venkatraman E S; Barakat R R; Hoskins W J
Stage IV ovarian cancer: impact of surgical debulking.
Gynecologic oncology 1997;64(1):9-12.
1996: McGuire W P; Hoskins W J; Brady M F; Kucera P R; Partridge E E; Look K Y; Clarke-Pearson D L; Davidson M
Cyclophosphamide and cisplatin versus paclitaxel and cisplatin: a phase III randomized trial in patients with suboptimal stage III/IV ovarian cancer (from the Gynecologic Oncology Group).
Seminars in oncology 1996;23(5 Suppl 12):40-7.
1996: Abu-Rustum N R; Barakat R R; Siegel P L; Venkatraman E; Curtin J P; Hoskins W J
Second-look operation for epithelial ovarian cancer: laparoscopy or laparotomy?
Obstetrics and gynecology 1996;88(4 Pt 1):549-53.
1996: Stier E A; Barakat R R; Curtin J P; Brown C L; Jones W B; Hoskins W J
Laparotomy to complete staging of presumed early ovarian cancer.
Obstetrics and gynecology 1996;87(5 Pt 1):737-40.
1996: Curtin J P; Hoskins W J; Venkatraman E S; Almadrones L; Podratz K C; Long H; Teneriello M; Averette H A; Sevin B U
Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): a randomized phase III trial.
Gynecologic oncology 1996;61(1):3-10.
1996: Gogas H; Shapiro F; Aghajanian C; Fennelly D; Almadrones L; Hoskins W J; Spriggs D R
The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer.
Gynecologic oncology 1996;61(1):22-6.
1996: Markman M; Hakes T; Barakat R; Curtin J; Almadrones L; Hoskins W
Follow-up of Memorial Sloan-Kettering Cancer Center patients treated on National Cancer Institute Treatment Referral Center protocol 9103: paclitaxel in refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):796-9.
1996: Yin B W; Finstad C L; Kitamura K; Federici M G; Welshinger M; Kudryashov V; Hoskins W J; Welt S; Lloyd K O
Serological and immunochemical analysis of Lewis y (Ley) blood group antigen expression in epithelial ovarian cancer.
International journal of cancer. Journal international du cancer 1996;65(4):406-12.
1996: McGuire W P; Hoskins W J; Brady M F; Kucera P R; Partridge E E; Look K Y; Clarke-Pearson D L; Davidson M
Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
The New England journal of medicine 1996;334(1):1-6.
1995: Thigpen T; Vance R B; McGuire W P; Hoskins W J; Brady M
The role of paclitaxel in the management of coelomic epithelial carcinoma of the ovary: a review with emphasis on the Gynecologic Oncology Group experience.
Seminars in oncology 1995;22(6 Suppl 14):23-31.
1995: Francis P; Rowinsky E; Schneider J; Hakes T; Hoskins W; Markman M
Phase I feasibility and pharmacologic study of weekly intraperitoneal paclitaxel: a Gynecologic Oncology Group pilot Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2961-7.
1995: Barakat R R; Benjamin I; Lewis J L; Saigo P E; Curtin J P; Hoskins W J
Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential.
Gynecologic oncology 1995;59(3):390-3.
1995: Kornblith A B; Thaler H T; Wong G; Vlamis V; Lepore J M; Loseth D B; Hakes T; Hoskins W J; Portenoy R K
Quality of life of women with ovarian cancer.
Gynecologic oncology 1995;59(2):231-42.
1995: Curtin J P; Saigo P; Slucher B; Venkatraman E S; Mychalczak B; Hoskins W J
Soft-tissue sarcoma of the vagina and vulva: a clinicopathologic study.
Obstetrics and gynecology 1995;86(2):269-72.
1995: McGuire W P; Hoskins W J; Brady M F; Homesley H D; Creasman W T; Berman M L; Ball H; Berek J S; Woodward J
Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1589-99.
1995: Markman M; Francis P; Rowinsky E; Hoskins W
Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?
Seminars in oncology 1995;22(3 Suppl 6):84-7.
1995: Poynor E A; Barakat R R; Hoskins W J
Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Gynecologic oncology 1995;57(2):158-64.
1995: Fennelly D; Schneider J; Spriggs D; Bengala C; Hakes T; Reich L; Barakat R; Curtin J; Moore M A; Hoskins W
Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1160-6.
1995: Vaccarello L; Rubin S C; Vlamis V; Wong G; Jones W B; Lewis J L; Hoskins W J
Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
Gynecologic oncology 1995;57(1):61-5.
1994: Benjamin I; Barakat R R; Curtin J P; Jones W B; Lewis J L; Hoskins W J
Blood transfusion for radical hysterectomy before and after the discovery of transfusion-related human immunodeficiency virus infection.
Obstetrics and gynecology 1994;84(6):974-8.
1994: Hoskins W J
Epithelial ovarian carcinoma: principles of primary surgery.
Gynecologic oncology 1994;55(3 Pt 2):S91-6.
1994: Barakat R R; Wong G; Curtin J P; Vlamis V; Hoskins W J
Tamoxifen use in breast cancer patients who subsequently develop corpus cancer is not associated with a higher incidence of adverse histologic features.
Gynecologic oncology 1994;55(2):164-8.
1994: Vaccarello L; Berghella V; Rubin S C; Hoskins W J
Distribution of intraperitoneal chemotherapy into the pleural cavity.
Obstetrics and gynecology 1994;84(4 Pt 2):714-7.
1994: Curtin J P; Barakat R R; Hoskins W J
Ovarian disease in women with breast cancer.
Obstetrics and gynecology 1994;84(3):449-52.
1994: Portenoy R K; Kornblith A B; Wong G; Vlamis V; Lepore J M; Loseth D B; Hakes T; Foley K M; Hoskins W J
Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms.
Cancer 1994;74(3):907-15.
1994: Hoskins W J; McGuire W P; Brady M F; Homesley H D; Creasman W T; Berman M; Ball H; Berek J S
The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
American journal of obstetrics and gynecology 1994;170(4):974-9; discussion 979-80.
1994: Rubin S C; Finstad C L; Federici M G; Scheiner L; Lloyd K O; Hoskins W J
Prevalence and significance of HER-2/neu expression in early epithelial ovarian cancer.
Cancer 1994;73(5):1456-9.
1994: Levenback C; Curtin J; Johnston D; Rubin S C; Yeh S; Hoskins W
Image analysis of the distribution of intraperitoneally administered fluids in patients with ovarian cancer.
European journal of gynaecological oncology 1994;15(5):345-51.
1993: Davidson S A; Rubin S C; Mychalczak B; Saigo P E; Lewis J L; Chapman D; Hoskins W J
Limited-field radiotherapy as salvage treatment of localized persistent or recurrent epithelial ovarian cancer.
Gynecologic oncology 1993;51(3):349-54.
1993: Rubin S C; Kostakoglu L; Divgi C; Federici M G; Finstad C L; Lloyd K O; Larson S M; Hoskins W J
Biodistribution and intraoperative evaluation of radiolabeled monoclonal antibody MX35 in patients with epithelial ovarian cancer.
Gynecologic oncology 1993;51(1):61-6.
1993: Jones W B; Mercer G O; Lewis J L; Rubin S C; Hoskins W J
Early invasive carcinoma of the cervix.
Gynecologic oncology 1993;51(1):26-32.
1993: Rubin S C; Wong G Y; Curtin J P; Barakat R R; Hakes T B; Hoskins W J
Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
Obstetrics and gynecology 1993;82(1):143-7.
1993: Rubin S C; Jones W B; Curtin J P; Barakat R R; Hakes T B; Hoskins W J
Second-look laparotomy in stage I ovarian cancer following comprehensive surgical staging.
Obstetrics and gynecology 1993;82(1):139-42.
1993: Provencher D M; Finstad C L; Saigo P E; Rubin S C; Hoskins W J; Federici M G; Stockert E; Lloyd K O; Lewis J L
Comparison of antigen expression on fresh and cultured ascites cells and on solid tumors of patients with epithelial ovarian cancer.
Gynecologic oncology 1993;50(1):78-83.
1993: Reichman B; Markman M; Hakes T; Rubin S; Jones W; Curtin J; Barakat R; Almadrones L; Lewis J L; Hoskins W
Mitomycin-C plus a 3-day continuous intravenous infusion of 5-fluorouracil: an inactive salvage regimen for platinum-resistant ovarian carcinoma.
Gynecologic oncology 1993;50(1):30-3.
1993: Markman M; Reichman B; Hakes T; Rubin S; Lewis J L; Jones W; Barakat R; Curtin J; Almadrones L; Hoskins W
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancer.
Gynecologic oncology 1993;50(1):100-4.
1993: Plante M; Wong G Y; Nisselbaum J S; Almadrones L; Hoskins W J; Rubin S C
Relationship between saliva and serum CA 125 in women with and without epithelial ovarian cancer.
Obstetrics and gynecology 1993;81(6):989-92.
1993: Markman M; Hakes T; Reichman B; Rubin S; Curtin J; Barakat R; Jones W; Lewis J L; Almadrones L; Hoskins W
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatment.
Gynecologic oncology 1993;49(2):185-9.
1993: Markman M; Reichman B; Hakes T; Rubin S; Jones W; Lewis J L; Barakat R; Curtin J; Almadrones L; Hoskins W
The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.
Gynecologic oncology 1993;49(2):172-6.
1993: Hoskins W J
Surgical staging and cytoreductive surgery of epithelial ovarian cancer.
Cancer 1993;71(4 Suppl):1534-40.
1993: Rubin S C; Kairemo K J; Brownell A L; Daghighian F; Federici M G; Pentlow K S; Finn R D; Lambrecht R M; Hoskins W J; Lewis J L
High-resolution positron emission tomography of human ovarian cancer in nude rats using 124I-labeled monoclonal antibodies.
Gynecologic oncology 1993;48(1):61-7.
1993: Thigpen T; Brady M F; Omura G A; Creasman W T; McGuire W P; Hoskins W J; Williams S
Age as a prognostic factor in ovarian carcinoma. The Gynecologic Oncology Group experience.
Cancer 1993;71(2 Suppl):606-14.
1992: Markman M; Hakes T; Reichman B; Barakat R; Curtin J; Jones W; Lewis J L; Rubin S; Almadrones L; Hoskins W
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
Seminars in oncology 1992;19(6 Suppl 14):25-7.
1992: Markman M; Reichman B; Hakes T; Rubin S; Jones W; Lewis J L; Barakat R; Curtin J; Almadrones L; Hoskins W
Phase 2 trial of intraperitoneal carboplatin and etoposide as salvage treatment of advanced epithelial ovarian cancer.
Gynecologic oncology 1992;47(3):353-7.
1992: Hoskins W J; Bundy B N; Thigpen J T; Omura G A
The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.
Gynecologic oncology 1992;47(2):159-66.
1992: Barakat R R; Rubin S C; Wong G; Saigo P E; Markman M; Hoskins W J
Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases.
Obstetrics and gynecology 1992;80(4):660-4.
1992: Barakat R R; Sararian K; Shepherd G; Weinberger M; Hoskins W J
Allergy to latex surgical gloves: an unfamiliar cause of intraoperative anaphylaxis.
Gynecologic oncology 1992;46(3):381-3.
1992: Markman M; Reichman B; Hakes T; Lewis J L; Jones W; Rubin S; Barakat R; Curtin J; Almadrones L; Hoskins W
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1479-84.
1992: Rubin S C; Hoskins W J; Saigo P E; Nori D; Mychalczak B; Chapman D; Lewis J L
Management of endometrial adenocarcinoma with cervical involvement.
Gynecologic oncology 1992;45(3):294-8.
1992: Hakes T B; Chalas E; Hoskins W J; Jones W B; Markman M; Rubin S C; Chapman D; Almadrones L; Lewis J L
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma.
Gynecologic oncology 1992;45(3):284-9.
1992: Rubin S C; Federici M G; Lloyd K O; Lewis J L; Hoskins W J
Characterization of a human endometrial carcinoma cell line producing intraperitoneal tumor growth in immunodeficient mice.
Gynecologic oncology 1992;45(3):273-8.
1992: Trimble E L; Lewis J L; Williams L L; Curtin J P; Chapman D; Woodruff J M; Rubin S C; Hoskins W J
Management of vulvar melanoma.
Gynecologic oncology 1992;45(3):254-8.
1992: Levenback C; Rubin S C; McCormack P M; Hoskins W J; Atkinson E N; Lewis J L
Resection of pulmonary metastases from uterine sarcomas.
Gynecologic oncology 1992;45(2):202-5.
1992: Markman M; Hakes T; Reichman B; Lewis J L; Rubin S; Jones W; Almadrones L; Pizzuto F; Hoskins W
Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(2):243-8.
1992: Markman M; Jones W; Lewis J L; Rubin S; Hakes T; Reichman B; Barakat R; Curtin J; Almadrones L; Hoskins W
Impact of laparotomy finding of significant intraabdominal adhesions on the surgically defined complete response rate to subsequent salvage intraperitoneal chemotherapy.
Journal of cancer research and clinical oncology 1992;118(2):163-5.
1992: Markman M; Reichman B; Hakes T; Curtin J; Barakat R; Rubin S; Jones W; Lewis J L; Almadrones L; Hoskins W
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapy.
Journal of cancer research and clinical oncology 1992;118(5):391-4.
1992: Markman M; Reichman B; Hakes T; Barakat R; Curtin J; Rubin S; Jones W; Lewis J L; Almadrones L; Hoskins W
Salvage intraperitoneal therapy of small-volume residual ovarian cancer: impact of pretreatment finding of peritoneal carcinomatosis on the surgical complete response rate.
Journal of cancer research and clinical oncology 1992;118(3):235-7.
1992: Markman M; Hakes T; Reichman B; Curtin J; Barakat R; Rubin S; Jones W; Lewis J L; Almadrones L; Hoskins W
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancer.
Journal of cancer research and clinical oncology 1992;119(1):55-7.
1991: Trimble E L; Karlan B Y; Lagasse L D; Hoskins W J
Diagnosing the correct ovarian cancer syndrome.
Obstetrics and gynecology 1991;78(6):1023-6.
1991: Trimble E L; Saigo P E; Freeberg G W; Rubin S C; Hoskins W J
Peritoneal sarcoidosis and elevated CA 125.
Obstetrics and gynecology 1991;78(5 Pt 2):976-7.
1991: Reichman B; Markman M; Hakes T; Budnick A; Rubin S; Jones W; Almadrones L; Lewis J L; Hoskins W
Phase II trial of high-dose cisplatin with sodium thiosulfate nephroprotection in patients with advanced carcinoma of the uterine cervix previously untreated with chemotherapy.
Gynecologic oncology 1991;43(2):159-63.
1991: Markman M; Reichman B; Hakes T; Jones W; Lewis J L; Rubin S; Almadrones L; Hoskins W
Responses to second-line cisplatin-based intraperitoneal therapy in ovarian cancer: influence of a prior response to intravenous cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(10):1801-5.
1991: Barakat R R; Rubin S C; Saigo P E; Chapman D; Lewis J L; Jones W B; Hakes T B; Markman M; Reichman B; Hoskins W J
Cisplatin-based combination chemotherapy in carcinoma of the fallopian tube.
Gynecologic oncology 1991;42(2):156-60.
1991: Rubin S C; Hoskins W J; Saigo P E; Chapman D; Hakes T B; Markman M; Reichman B; Almadrones L; Lewis J L
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.
Gynecologic oncology 1991;42(2):137-41.
1991: Markman M; Hakes T; Reichman B; Lewis J L; Rubin S; Jones W; Almadrones L; Hoskins W
Phase II trial of weekly or biweekly intraperitoneal mitoxantrone in epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):978-82.
1991: Markman M; Rothman R; Hakes T; Reichman B; Lewis J L; Rubin S; Jones W; Almadrones L; Hoskins W
Late effects of cisplatin-based chemotherapy on renal function in patients with ovarian carcinoma.
Gynecologic oncology 1991;41(3):217-9.
1991: Hoskins W J; Rubin S C
Surgery in the treatment of patients with advanced ovarian cancer.
Seminars in oncology 1991;18(3):213-21.
1991: Davidson S A; Rubin S C; Markman M; Jones W B; Hakes T B; Reichman B; Almadrones L; Chapman D; Lewis J L; Hoskins W J
Intraperitoneal chemotherapy: analysis of complications with an implanted subcutaneous port and catheter system.
Gynecologic oncology 1991;41(2):101-6.
1991: Markman M; Rothman R; Hakes T; Reichman B; Hoskins W; Rubin S; Jones W; Almadrones L; Lewis J L
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):389-93.
1991: Markman M; Hakes T; Reichman B; Hoskins W; Rubin S; Jones W; Almadrones L; Yordan E L; Eriksson J; Lewis J L
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(2):204-10.
1991: Rubin S C; Finstad C L; Hoskins W J; Provencher D; Federici M G; Lloyd K O; Lewis J L
Analysis of antigen expression at multiple tumor sites in epithelial ovarian cancer.
American journal of obstetrics and gynecology 1991;164(2):558-63.
1991: Curtin J P; Hoskins W J; Rubin S C; Jones W B; Hakes T B; Markman M M; Reichman B; Almadrones L; Lewis J L
Chemotherapy-induced neutropenia and fever in patients receiving cisplatin-based chemotherapy for ovarian malignancy.
Gynecologic oncology 1991;40(1):17-20.
1991: Markmann M; Rothman R; Reichman B; Hakes T; Lewis J L; Rubin S; Jones W; Almadrones L; Hoskins W
Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer.
Journal of cancer research and clinical oncology 1991;117(2):89-90.
1990: Curtin J P; Rubin S C; Jones W B; Hoskins W J; Lewis J L
Paget's disease of the vulva.
Gynecologic oncology 1990;39(3):374-7.
1990: Finstad C L; Saigo P E; Rubin S C; Federici M G; Provencher D M; Hoskins W J; Lewis J L; Lloyd K O
Immunohistochemical localization of P-glycoprotein in adult human ovary and female genital tract of patients with benign gynecological conditions.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1990;38(11):1677-81.
1990: Ng L W; Rubin S C; Hoskins W J; Jones W B; Hakes T B; Markman M; Reichman B; Almadrones L; Lewis J L
Aggressive chemosurgical debulking in patients with advanced ovarian cancer.
Gynecologic oncology 1990;38(3):358-63.
1990: Rubin S C; Finstad C L; Hoskins W J; Saigo P E; Provencher D M; Federici M G; Hakes T B; Markman M; Reichman B S; Lloyd K O
Expression of P-glycoprotein in epithelial ovarian cancer: evaluation as a marker of multidrug resistance.
American journal of obstetrics and gynecology 1990;163(1 Pt 1):69-73.
1990: Markman M; George M; Hakes T; Reichman B; Hoskins W; Rubin S; Jones W; Almadrones L; Lewis J L
Phase II trial of intraperitoneal mitoxantrone in the management of refractory ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(1):146-50.
1990: Berchuck A; Rubin S C; Hoskins W J; Saigo P E; Pierce V K; Lewis J L
Treatment of endometrial stromal tumors.
Gynecologic oncology 1990;36(1):60-5.
1989: Hoskins W J
Surgical procedures in gynecologic oncology.
Current opinion in oncology 1989;1(1):89-96.
1989: Buchsbaum H J; Brady M F; Delgado G; Miller A; Hoskins W J; Manetta A; Sutton G
Surgical staging of carcinoma of the ovaries.
Surgery, gynecology & obstetrics 1989;169(3):226-32.
1989: Rubin S C; Finstad C L; Hoskins W J; Federici M G; Lloyd K O; Lewis J L
A longitudinal study of antigen expression in epithelial ovarian cancer.
Gynecologic oncology 1989;34(3):389-94.
1989: Reichman B; Markman M; Hakes T; Hoskins W; Rubin S; Jones W; Almadrones L; Ochoa M; Chapman D; Saigo P
Intraperitoneal cisplatin and etoposide in the treatment of refractory/recurrent ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1327-32.
1989: Hoskins W J; Rubin S C; Dulaney E; Chapman D; Almadrones L; Saigo P; Markman M; Hakes T; Reichman B; Jones W B
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinoma.
Gynecologic oncology 1989;34(3):365-71.
1989: Rubin S C; Hoskins W J; Markman M; Federici M; Lloyd K O; Lewis J L
Synergistic activity of tumor necrosis factor and interferon in a nude mouse model of human ovarian cancer.
Gynecologic oncology 1989;34(3):353-6.
1989: Rubin S C; Benjamin I; Hoskins W J; Pierce V K; Lewis J L
Intestinal surgery in gynecologic oncology.
Gynecologic oncology 1989;34(1):30-3.
1989: Markman M; Hakes T; Reichman B; Hoskins W; Rubin S; Jones W; Almadones L; Lewis J L
Intraperitoneal therapy in the management of ovarian carcinoma.
The Yale journal of biology and medicine 1989;62(4):393-403.
1989: Rubin S C; Hoskins W J; Benjamin I; Lewis J L
Palliative surgery for intestinal obstruction in advanced ovarian cancer.
Gynecologic oncology 1989;34(1):16-9.
1989: Curtin J P; Rubin S C; Hoskins W J; Hakes T B; Lewis J L
Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration.
Obstetrics and gynecology 1989;73(5 Pt 2):893-5.
1989: Rubin S C; Hoskins W J; Markman M; Hakes T; Lewis J L
Long-term access to the peritoneal cavity in ovarian cancer patients.
Gynecologic oncology 1989;33(1):46-8.
1989: Fuller A F; Elliott N; Kosloff C; Hoskins W J; Lewis J L
Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix.
Gynecologic oncology 1989;33(1):34-9.
1989: Fort M G; Pierce V K; Saigo P E; Hoskins W J; Lewis J L
Evidence for the efficacy of adjuvant therapy in epithelial ovarian tumors of low malignant potential.
Gynecologic oncology 1989;32(3):269-72.
1989: Rubin S C; Hoskins W J; Hakes T B; Markman M; Reichman B S; Chapman D; Lewis J L
Serum CA 125 levels and surgical findings in patients undergoing secondary operations for epithelial ovarian cancer.
American journal of obstetrics and gynecology 1989;160(3):667-71.
1989: Markman M; Reichman B; Hakes T; Hoskins W; Rubin S; Jones W; Lewis J L
Intraperitoneal chemotherapy as treatment for ovarian carcinoma and gastrointestinal malignancies: the Memorial Sloan-Kettering Cancer Center experience).
Acta medica Austriaca 1989;16(3-4):65-7.
1988: Rubin S C; Hoskins W J; Hakes T B; Markman M; Cain J M; Lewis J L
Recurrence after negative second-look laparotomy for ovarian cancer: analysis of risk factors.
American journal of obstetrics and gynecology 1988;159(5):1094-8.
1988: Rubin S C; Dulaney E D; Markman M; Hoskins W J; Saigo P E; Lewis J L
Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
Obstetrics and gynecology 1988;71(6 Pt 1):851-3.
1988: Berchuck A; Rubin S C; Hoskins W J; Saigo P E; Pierce V K; Lewis J L
Treatment of uterine leiomyosarcoma.
Obstetrics and gynecology 1988;71(6 Pt 1):845-50.
1988: D'Acquisto R; Markman M; Hakes T; Rubin S; Hoskins W; Lewis J L
A phase I trial of intraperitoneal recombinant gamma-interferon in advanced ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):689-95.
1988: Reichman B; Markman M; Hakes T; Kemeny N; Kelsen D; Hoskins W; Rubin S; Lewis J L
Phase I trial of concurrent intraperitoneal and continuous intravenous infusion of fluorouracil in patients with refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):158-62.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

William Hoskins

Research Profile (preview)

Disorders

Concepts & Ideas

Chemicals & Drugs

Procedures

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of William Hoskins (preview)

All Publications